Telix
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Australia · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
55 Flemington Rd L 4, North Melbourne, V...Phone Number
+61 330933897Website
www.telixpharma.comRevenue
$803.8 MillionStock Symbol
TLXIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Telix
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, founded in 2015 and publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, commonly referred to as theranostics, which use molecularly targeted radiation to both image and treat cancer. Telix's pipeline is focused on urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma), and bone marrow conditioning. Its lead commercial product, Illuccix, is an approved PSMA-PET/CT imaging agent for prostate cancer with regulatory clearance from the FDA, Australia's TGA, and Health Canada.Explore more
Telix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Telix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Telix recently announced quarterly report
Check if Telix has recently received funding, and reach out quickly before it becomes old news!
Telix, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Telix is spiking on competitors!
Funding: Get notified immidiatlly once Telix has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Telix had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Telix
Product Launch: Get notified when Telix launches new products
Recommended Actions
Reach out to Masked Content who joined Telix as Masked Content
Find 3 more new buyers
Compare Similar Companies to Telix
Compare insights from companies similar to Telix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Telix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Telix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Telix.
Telix financials insights
Gather financial insights about Telix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Corporate Investment
$25M
2024
Share Placement
$434M
Share Placement
$434M
Telix Tech Stack
A closer look at the technologies used by Telix
Most Recent Scoops
Open Position
Open Position
Person-Based
Finance, Tax
Partnership
Telix has announced a co-development and co-commercialization collaboration with Regeneron to advance next-generation radiopharmaceutical candidates, with the agreement initially covering four compounds and including an option for four additional compounds. The collaboration focuses on combining Regeneron's antibody-drug conjugate platform with radiopharmaceutical activity to develop radioactive ADC compounds.
Partnership
Open Position
Telix News & Media
Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic Agents Transcript
Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic Agents June 29, 2026 5:00 PM...Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces an educational webinar exploring the unmet needs in neurologic oncology (specifically glioma and glioblastoma) and how theranostics may help address these.Telix Pharmaceuticals (TLX), United Imaging Healthcare Form Strategic Theranostics Research Partnership
Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the best new stocks to buy with the huge upside potential. On June 2, Telix Pharmaceuticals and United Imaging Healthcare signed an MoU to establish a strategic research collaboration in the US. This partnership aims to advance integrated theranostics by combining United Imaging’s advanced scanner platforms, software, and […]Telix and United Imaging Announce Strategic Theranostics Collaboration
MELBOURNE, Australia and INDIANAPOLIS and HOUSTON, June 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) and United Imaging Healthcare North America, Inc. (“United Imaging”) today announce the signing of a Memorandum of Understanding (MOU) to evaluate a strategic research collaboration in the United States (U.S.) focused on advancing integrated theranostics solutions.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Telix
Sign Up For FreeTo access detailed company insights
Telix Pharmaceuticals is a global, commercial-stage biopharmaceutical company headquartered in North Melbourne, Australia, founded in 2015 and publicly listed on the Australian Securities Exchange and Nasdaq under the ticker TLX. The company specializes in the development and commercialization of diagnostic and therapeutic radiopharmaceuticals, com... Read More
